Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction

Table 2 Correlation between Presepsin, age, clinical score systems, and laboratory markers of inflammation

The values are presented as Spearman’s r of 190 runners for Presepsin. Abbreviations s, e, q SOFA, simplified, early, quick sequential organ failure assessment; NEWS2, National Early Warning Score 2; PSI, Pneumonia Severity Index; PCT, Procalcitonin; CRP, C-reactive protein; NLR, Neutrophil-to-lymphocyte ratio; MLR, Monocyte-to-lymphocyte ratio; PLR, Platelet-to-lymphocyte ratio; LCR, Lymphocyte-to-C-reactive protein ratio; CAR, C-reactive protein-to-albumin ratio; SIRI, Systemic inflammation response index; SII: Systemic inflammation index. SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count; SII = (Neutrophil count × Platelet count) / Lymphocyte count
*p-value < 0.05 was considered significant

ISSN: 1743-422X